(Q34769876)

4 August 2017

1 reference

title

Mantle cell lymphoma: a biological and therapeutic paradigm (English)

1 reference

4 August 2017

1 reference

Didier Decaudin

1

1 reference

4 August 2017

language of work or name

1 reference

1 April 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

43

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

773-781

1 reference

Malignant lymphomas of B-cell type

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Patterns of survival in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Mantle cell lymphoma is characterized by inactivation of the ATM gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Ataxia telangiectasia gene mutations in leukaemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Enhanced phosphorylation of p53 by ATM in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Interaction between ATM protein and c-Abl in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Biallelic mutations in the ATM gene in T-prolymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

CNS involvement in mantle-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Central nervous system involvement in patients with mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Mantle-cell lymphoma: a population-based clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Gemcitabine for relapsed or resistant lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Successful allogeneic stem-cell transplantation with prophylactic stepwise G-CSF primed-DLIs for relapse after autologous transplantation in mantle cell lymphoma: a case report and literature review on the evidence of GVL effects in MCL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin’s lymphomas: a single center experience on 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190290016881

10.1080/10428190290016881

21 January 2018

Identifiers

DOI

1 reference

release_mxmuxg6a3ndm3mdd3iozxfhqwe

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mxmuxg6a3ndm3mdd3iozxfhqwe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference